  Research articlePromoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancerErik Noetzel1 1 Molecular Oncology Group, Institute of Pathology, University Hospital of the RWTH Aachen, Aachen, Germany 2 Department of Gynaecology and Obstetrics, Heinrich-Heine University, Düsseldorf, Germany 3 Medical Clinic IV, University Hospital of the RWTH Aachen, Aachen, Germany 4 Department of Gynaecology and Obstetrics, University of Regensburg, Regensburg, Germany 5 Institute of Pathology, University of Erlangen, Erlangen, Germany
BMC Cancer 2008, 8:154doi:10.1186/1471-2407-8-154
Additional filesAdditional file 1: "Touchdown PCR for ID4 mRNA expression analysis" Format: PDF Size: 9KB Download file This file can be viewed with: Adobe Acrobat Reader Additional file 2: "Positive controls for the immunohistochemical staining with normal and tumourous colon tissues for a polyclonal ID4 antibody (sc-491)." A) and C) are negative controls without ID4 antibody incubation for normal and tumourous colon tissues, respectively. B) Intensive cytoplasmatic staining of a normal colon tissue. D) Negative ID4 protein staining for an infiltrating colon carcinoma (G2, pT2, pN0, pMx). Format: PDF Size: 76KB Download file This file can be viewed with: Adobe Acrobat Reader |
|
|
|
 |  | Log on / register Feedback | Support | My details |
on Google Scholar
author email
corresponding author email|
|
| © 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media. |